Treatment for metabolic diseases in neonates typically involves dietary management to restrict certain substances that the body cannot process. For example, infants with PKU require a diet low in phenylalanine, while those with Galactosemia must avoid galactose-containing foods. In some cases, enzyme replacement therapy or medications may be used to manage the condition. Early intervention and treatment are crucial to prevent severe complications and promote normal development.
